In 2015, mechanical thrombectomy became the standard of care for treating stroke caused by large vessel occlusion (LVO), which is often associated with worse outcomes. Despite its well-known benefits, the uptake in the utilization of this procedure has been slower than many stroke specialists have hoped. Dileep Yavagal, M.D., professor of clinical neurology, University of Miami, described it as “a step forward not just in stroke but in all of medicine” to NeurologyLive. As such, he and a group of other experts in stroke, as part of the Society of Vascular and Interventional Neurology (SVIN) came together to start the Mechanical Thrombectomy 2020+ (MT2020+) initiative.